欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/4917/001
药品名称Varilrix, powder and solvent for solution for injection in a prefilled syringe
活性成分
    • Varicella virus, live attenuated 3.3 log10 PFU/dose
剂型Powder and solvent for solution for injection
上市许可持有人GlaxoSmithKline GmbH & Co.KG
参考成员国 - 产品名称Germany (DE)
Varilrix
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Malta (MT)
许可日期2021/03/24
最近更新日期2025/09/10
药物ATC编码
    • J07BK01 varicella, live attenuated
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase